Newsletter Archive

Autism Research Institute
Autism Research Review International
1987 to 2006, Volumes 1 to 20

a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z  

A

"A" Book: A Collection of Writings from the Advocate" (Sposato), 1989, Vol. 03(4) pp. 7
a-melanocyte stimulating hormone (a-MSH), 2003, Vol. 17(1) pp. 7
ABA. See Applied Behavior Analysis, Lovaas, O. Ivar
Abe, Tokuichiro, 1989, Vol. 03(2) pp. 1
Abenhaim, Lucien, 1996, Vol. 10(3) pp. 4; 1997, Vol. 11(1) pp. 5.
Abilify, 2003, Vol. 17(3) pp. 2
AbleLink Technologies, 2001, Vol. 15(3) pp. 5
aboriginal children, 1998, Vol. 12(1) pp. 3; 2000, Vol. 14(1) pp. 5; 2002, Vol. 16(4) pp. 3.
aborted fetal cell lines, 2003, Vol. 17(3) pp. 7
ABR (auditory brainstem response) test, 1988, Vol. 02(4) pp. 4; 1993, Vol. 07(2) pp. 4.
academics. See education
Accardo, Pasquale, 1999, Vol. 13(4) pp. 7
Access to Medical Treatment Act, 1997, Vol. 11(3) pp. 3 See also legislation
ACE inhibitors, 2006, Vol. 20(2) pp. 7
acetylcholine, 1998, Vol. 12(4) pp. 2; 2001, Vol. 15(3) pp. 7; 2002, Vol. 16(4) pp. 5; 2004, Vol. 18(2) pp. 5.
Achieving the Complete School (Biklen), 1993, Vol. 07(1) pp. 3
acidophilus, 1988, Vol. 02(2) pp. 3
acidosis, lactic, 1987, Vol. 01(3) pp. 4
aciduria. See amino-aciduria
ACM. See Arnold-Chiari Malformations
acquired autism, 1988, Vol. 02(1) pp. 4; 1994, Vol. 08(4) pp. 4.
acquired epileptic aphasia. See Landau-Kleffner syndrome
acrocyanosis, 1990, Vol. 04(3) pp. 4
acrodynia, 2000, Vol. 14(4) pp. 3
ACTH peptides, 1989, Vol. 03(3) pp. 7; 1994, Vol. 08(1) pp. 2.
Actifed products, 2003, Vol. 17(1) pp. 5
Actos, 2006, Vol. 20(3) pp. 7; 2006, Vol. 20(4) pp. 2.
acyclovir, 1997, Vol. 11(2) pp. 2
ADA (adenosine deaminase), 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(2) pp. 2; 2003, Vol. 17(4) pp. 4.
Adams, James B., 2001, Vol. 15(4) pp. 7; 2005, Vol. 19(1) pp. 2; 2006, Vol. 20(3) pp. 6; 2006, Vol. 20(4) pp. 6.
adaptive behavior, 2002, Vol. 16(1) pp. 2
adaptive technology. See communication devices
ADD. See attention deficit disorder
Adderall, 2005, Vol. 19(1) pp. 6; 2006, Vol. 20(1) pp. 5; 2006, Vol. 20(2) pp. 7.
addiction, 1992, Vol. 06(1) pp. 1; 1992, Vol. 06(2) pp. 4.
additives, 2000, Vol. 14(1) pp. 2; 2003, Vol. 17(3) pp. 5; 2004, Vol. 18(3) pp. 2; 2005, Vol. 19(4) pp. 1.
Adelinis, John D., 2000, Vol. 14(1) pp. 5
adenosine, 1990, Vol. 04(1) pp. 2
adenosine deaminase (ADA), 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(2) pp. 2; 2003, Vol. 17(4) pp. 4.
adenosine triphosphate, 1999, Vol. 13(3) pp. 4
adenylosuccinate lyase, 1987, Vol. 01(2) pp. 1; 1996, Vol. 10(2) pp. 4; 2001, Vol. 15(1) pp. 7.
ADHD. See attention deficit hyperactivity disorder
Adler, Lenard, 1992, Vol. 06(2) pp. 7; 1994, Vol. 08(3) pp. 1; 1998, Vol. 12(3) pp. 5.
adrenaleukodystrophy (ALD), 2005, Vol. 19(2) pp. 7
adrenaline, 1988, Vol. 02(1) pp. 4; 1994, Vol. 08(4) pp. 4.
Adriana Foundation, 1991, Vol. 05(1) pp. 7; 1992, Vol. 06(1) pp. 3.
adult autistics, 1989, Vol. 03(3) pp. 2
Adults with Autism in European Farm Communities (Giddan and Giddan), 1993, Vol. 07(2) pp. 2
advertising, 2003, Vol. 17(3) pp. 3
Advisory Committee on Immunization Practises (ACIP), 2004, Vol. 18(2) pp. 6
"advozealots," 1993, Vol. 07(4) pp. 3; 1994, Vol. 08(1) pp. 3.
aerophagia, 2001, Vol. 15(2) pp. 4–5
affection

Pepcid for, 1999, Vol. 13(2) pp. 2
sensory integration therapy for, 1999, Vol. 13(2) pp. 5
supplements for, 1998, Vol. 12(1) pp. 7; 2000, Vol. 14(2) pp. 7.
training for, 1988, Vol. 02(4) pp. 5

affiliative behavior, 1992, Vol. 06(3) pp. 4; 1993, Vol. 07(4) pp. 4; 1996, Vol. 10(3) pp. 2; 2001, Vol. 15(1) pp. 4; 2002, Vol. 16(4) pp. 5.
African Americans and drug reactions, 2000, Vol. 14(1) pp. 4
Afzal, Nadeem, 2003, Vol. 17(4) pp. 5
age appropriate activities, 1994, Vol. 08(2) pp. 5
Agency for Health Care Policy and Research, 1994, Vol. 08(4) pp. 2
Agent Orange, 1992, Vol. 06(2) pp. 1; 1992, Vol. 06(3) pp. 2; 1997, Vol. 11(4) pp. 2. See also dioxin
aggression

divalproex sodium for, 2005, Vol. 19(4) pp. 4
galantamine for, 2006, Vol. 20(4) pp. 7
and lithium deficiency, 2006, Vol. 20(4) pp. 6
marijuana for, 2002, Vol. 16(2) pp. 7; 2002, Vol. 16(3) pp. 7; 2003, Vol. 17(1) pp. 3.
naltrexone for, 1991, Vol. 05(3) pp. 4; 1991, Vol. 05(4) pp. 2.
nutritional interventions for, 2004, Vol. 18(4) pp. 7
and parasitic infections, 2004, Vol. 18(3) pp. 5
and puberty, 2005, Vol. 19(1) pp. 3
Reminyl for, 2006, Vol. 20(4) pp. 7
secretin for, 1998, Vol. 12(4) pp. 3; 1999, Vol. 13(1) pp. 3; 1999, Vol. 13(4) pp. 3; 2000, Vol. 14(1) pp. 7.
seizures and, 2005, Vol. 19(1) pp. 3
supplements for, 2005, Vol. 19(4) pp. 7

aggression, causes

as frontal lobe seizures, 1992, Vol. 06(1) pp. 4
and gastrointestinal pain, 2001, Vol. 15(4) pp. 3; 2003, Vol. 17(1) pp. 7.
during PMS, 1998, Vol. 12(3) pp. 6; 2000, Vol. 14(3) pp. 5; 2001, Vol. 15(1) pp. 4.

aggression, descriptions/types

in catatonic autistics, 2000, Vol. 14(4) pp. 4
as cyclical, 1995, Vol. 09(1) pp. 4
periodic aggression, 1992, Vol. 06(3) pp. 6; 1992, Vol. 06(4) pp. 6.
sibling-directed, 1999, Vol. 13(1) pp. 5
and subclinical seizures, 1995, Vol. 09(4) pp. 3

aggression, drugs for

buspirone, 1991, Vol. 05(4) pp. 4; 1994, Vol. 08(3) pp. 4; 1996, Vol. 10(1) pp. 4.
clomipramine, 1992, Vol. 06(4) pp. 5; 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 6; 1998, Vol. 12(1) pp. 4.
clozapine, 1996, Vol. 10(1) pp. 1; 1996, Vol. 10(3) pp. 2.
divalproex sodium (Depakote), 2000, Vol. 14(2) pp. 5; 2001, Vol. 15(3) pp. 5.
eltoprazine, 1992, Vol. 06(2) pp. 2
mecamylamine, 1998, Vol. 12(4) pp. 2
naltrexone, 1989, Vol. 03(3) pp. 1; 1991, Vol. 05(3) pp. 4.
No-Fenol, 2002, Vol. 16(1) pp. 3
olanzapine, 1999, Vol. 13(3) pp. 4
propranolol, 1990, Vol. 04(3) pp. 7
Prozac, 1991, Vol. 05(4) pp. 1; 1992, Vol. 06(3) pp. 4; 1993, Vol. 07(3) pp. 2; 1995, Vol. 09(1) pp. 1.
risperidone, 1996, Vol. 10(2) pp. 2; 1996, Vol. 10(4) pp. 7; 1997, Vol. 11(2) pp. 6; 1998, Vol. 12(2) pp. 4; 1999, Vol. 13(1) pp. 5; 2000, Vol. 14(1) pp. 5; 2000, Vol. 14(2) pp. 5.
sertraline (Zoloft), 1996, Vol. 10(4) pp. 2; 1998, Vol. 12(2) pp. 4.
Spirolactone, 1998, Vol. 12(4) pp. 7; 2006, Vol. 20(3) pp. 7.
SSRIs, 1997, Vol. 11(2) pp. 4
Tegretol, 1990, Vol. 04(2) pp. 2; 1992, Vol. 06(4) pp. 7.

aggression, supplements for

B6, 1992, Vol. 06(1) pp. 7; 1992, Vol. 06(2) pp. 6; 1992, Vol. 06(4) pp. 6; 1993, Vol. 07(1) pp. 7; 1993, Vol. 07(3) pp. 1; 1996, Vol. 10(4) pp. 7; 2001, Vol. 15(1) pp. 6; 2001, Vol. 15(4) pp. 3.
and beta-casomorphin, 1999, Vol. 13(2) pp. 1
calcium, 1998, Vol. 12(3) pp. 6
cod liver oil, 2000, Vol. 14(2) pp. 7
DMG, 1992, Vol. 06(1) pp. 7; 1996, Vol. 10(4) pp. 7; 2001, Vol. 15(4) pp. 3.
general, 2002, Vol. 16(4) pp. 4
magnesium, 1992, Vol. 06(1) pp. 6; 2001, Vol. 15(1) pp. 6.

aggression, therapies for

auditory integration training, 1999, Vol. 13(2) pp. 2
brief movement restriction, 1991, Vol. 05(4) pp. 5
choice expansion, 1994, Vol. 08(3) pp. 5
communication skills, 1987, Vol. 01(4) pp. 5
differential reinforcement of other behaviors (DRO), 1989, Vol. 03(1) pp. 5
gluten-free diet, 1999, Vol. 13(2) pp. 6
jobs as incentive, 1990, Vol. 04(3) pp. 1
meditation, 2003, Vol. 17(3) pp. 7
mood music, 1998, Vol. 12(1) pp. 5
non-aversives and aversives compared, 1988, Vol. 02(3) pp. 2
sensory integration therapy, 1997, Vol. 11(4) pp. 5
sensory stimulation, 1988, Vol. 02(4) pp. 6
and theory of mind, 1998, Vol. 12(4) pp. 6

agitation

in catatonic autistics, 2000, Vol. 14(4) pp. 4
and clomipramine, 1998, Vol. 12(1) pp. 4
diets for, 2002, Vol. 16(3) pp. 1
from Marinol, 2003, Vol. 17(3) pp. 6
from melatonin, 1999, Vol. 13(4) pp. 6
and olanzapine (Zyprexa), 2001, Vol. 15(1) pp. 4
and Prozac, 1998, Vol. 12(3) pp. 4; 1998, Vol. 12(4) pp. 1.
risperidone for, 1997, Vol. 11(1) pp. 2; 1997, Vol. 11(2) pp. 7.
and SSRIs, 1997, Vol. 11(2) pp. 4

agnus castus (chaste tree berry), 2001, Vol. 15(1) pp. 4
agoraphobia, 1999, Vol. 13(1) pp. 2
agranulocytosis, 1996, Vol. 10(1) pp. 1; 1996, Vol. 10(3) pp. 2.
Agrawal, Anshu, 2006, Vol. 20(4) pp. 6
Aguilar, Luis, 1997, Vol. 11(3) pp. 3
Ahearn, William H., 2003, Vol. 17(4) pp. 5
Ahlsen, Gunilla, 1994, Vol. 08(1) pp. 4
air swallowing, 2001, Vol. 15(2) pp. 5
AIT. See auditory integration training
Aitken, Kenneth, 2001, Vol. 15(2) pp. 6
akathisia, 1997, Vol. 11(1) pp. 4; 1999, Vol. 13(4) pp. 4; 2006, Vol. 20(2) pp. 2.
Akefeldt, Arne, 1992, Vol. 06(1) pp. 4
Akerly, M., 1991, Vol. 05(3) pp. 7
ALARM, Autism, 2004, Vol. 18(2) pp. 3
Alberta Teachers' Association, 1995, Vol. 09(4) pp. 7
Alberto, P., 2002, Vol. 16(2) pp. 5
Albright heriditary osteodystrophy (AHO), 1998, Vol. 12(1) pp. 4
albumin, 2002, Vol. 16(4) pp. 4
alcohol exposure, 1998, Vol. 12(1) pp. 5
alcoholism, 2000, Vol. 14(1) pp. 3
ALD (adrenaleukodystrophy), 2005, Vol. 19(2) pp. 7
Aldulaimi, D., 2002, Vol. 16(1) pp. 6
alertness, 1996, Vol. 10(3) pp. 7
Alevizos, B., 2003, Vol. 17(3) pp. 7
Alexander, Duane, 1989, Vol. 03(4) pp. 3; 1998, Vol. 12(4) pp. 3.
Ali, F.E., 2004, Vol. 18(3) pp. 4
Allen, George F. (U.S. Senator), 2004, Vol. 18(4) pp. 3
Allen, Greg, 1997, Vol. 11(2) pp. 4
Allen, Jane, 1993, Vol. 07(1) pp. 1
allergies

in autistics, 1993, Vol. 07(3) pp. 4; 2004, Vol. 18(2) pp. 7.
in cerebrum, 1989, Vol. 03(2) pp. 3
to composite woods, 2004, Vol. 18(4) pp. 7
to food colorings, 1995, Vol. 09(2) pp. 5
and food intolerances compared, 1989, Vol. 03(2) pp. 2; 1992, Vol. 06(3) pp. 6.
green tea for, 2002, Vol. 16(4) pp. 5
and middle-ear infections, 1992, Vol. 06(4) pp. 4; 1994, Vol. 08(4) pp. 2; 1997, Vol. 11(1) pp. 7.
to milk, 1996, Vol. 10(3) pp. 4
onset and types of, 1989, Vol. 03(3) pp. 6
pertussis and encephalitis, 1995, Vol. 09(1) pp. 1
and self-injury, 1997, Vol. 11(4) pp. 5
to tartrazine, 1995, Vol. 09(2) pp. 5

Allison, David B., 1993, Vol. 07(4) pp. 5
Allman, John Morgan, 2005, Vol. 19(2) pp. 4
allopurinol, 1990, Vol. 04(1) pp. 2
aloofness, 2000, Vol. 14(1) pp. 4; 2002, Vol. 16(3) pp. 1.
alpha interferon, 1995, Vol. 09(2) pp. 5
alpha linoleic acid, 2005, Vol. 19(4) pp. 2
alpha lipoic acid, 2006, Vol. 20(1) pp. 3
ALPS (autoimmune lymphoproliferative disease), 2000, Vol. 14(3) pp. 5
ALS (amyotropic lateral sclerosis), 1995, Vol. 09(2) pp. 4
Alsaadi, Taoufik, 2002, Vol. 16(4) pp. 4
alternating vision, 2006, Vol. 20(2) pp. 3
alternative medicine database, 2001, Vol. 15(1) pp. 7
Alternatives for People with Autism, Inc., 1988, Vol. 02(3) pp. 8
Alternatives to Punishment (Donnellan and LaVigna), 1988, Vol. 02(3) pp. 6; 1994, Vol. 08(3) pp. 6.
Altman, Reuben, 1995, Vol. 09(2) pp. 5
Altobelli, Lori, 1992, Vol. 06(2) pp. 1; 1993, Vol. 07(3) pp. 5; 1994, Vol. 08(1) pp. 4; 1994, Vol. 08(3) pp. 6; 1995, Vol. 09(3) pp. 3.
aluminum, 2000, Vol. 14(4) pp. 3; 2001, Vol. 15(2) pp. 1; 2003, Vol. 17(1) pp. 4; 2004, Vol. 18(3) pp. 2; 2006, Vol. 20(1) pp. 3.
Alzheimer's drugs, 2004, Vol. 18(2) pp. 5
amalgam fillings, 2000, Vol. 14(4) pp. 3
Aman, Michael G., 1990, Vol. 04(2) pp. 4; 1993, Vol. 07(4) pp. 4.
amantadine hydrochloride (Symmetrel), 2001, Vol. 15(4) pp. 2
Amaral, David, 2005, Vol. 19(1) pp. 7; 2006, Vol. 20(4) pp. 5.
ambidexterity, 1987, Vol. 01(4) pp. 2
ambient vision, 2006, Vol. 20(2) pp. 3
Ameer, Barbara, 1997, Vol. 11(3) pp. 6
amenorrhea, 1999, Vol. 13(4) pp. 4; 2001, Vol. 15(2) pp. 4.
American Academy of Child and Adolescent Psychiatry, 1994, Vol. 08(2) pp. 2
American Academy of Neurology, 2000, Vol. 14(3) pp. 4
American Academy of Pediatrics, 1994, Vol. 08(2) pp. 2; 2001, Vol. 15(3) pp. 2; 2002, Vol. 16(3) pp. 3; 2004, Vol. 18(2) pp. 3; 2006, Vol. 20(3) pp. 5.
American Association on Mental Retardation, 1994, Vol. 08(2) pp. 2
American Dietetic Association, 1993, Vol. 07(2) pp. 2
American Federation of Teachers, 1993, Vol. 07(4) pp. 2; 1995, Vol. 09(4) pp. 1.
American Medical Association, 1989, Vol. 03(2) pp. 2; 2001, Vol. 15(3) pp. 3.
American Psychiatric Association, 2001, Vol. 15(3) pp. 3; 2006, Vol. 20(3) pp. 5.
American Psychological Association, 1994, Vol. 08(2) pp. 2; 1994, Vol. 08(3) pp. 7.
American Speech-Language-Hearing Association
on facilitated communication, 1994, Vol. 08(3) pp. 7
amino acids

aspartate, 2005, Vol. 19(4) pp. 5
and B6, 1994, Vol. 08(1) pp. 2
carnitine, 1996, Vol. 10(3) pp. 4
catecholamines, 1987, Vol. 01(4) pp. 6; 2004, Vol. 18(4) pp. 4.
creatine, 1999, Vol. 13(3) pp. 4; 2003, Vol. 17(3) pp. 4.
and digestive enzymes, 1999, Vol. 13(2) pp. 1
free-form amino acids, 2002, Vol. 16(1) pp. 7
glutamate (or glutamic acid), 2003, Vol. 17(2) pp. 2; 2004, Vol. 18(2) pp. 2; 2005, Vol. 19(2) pp. 6; 2005, Vol. 19(3) pp. 2; 2005, Vol. 19(4) pp. 1.
homocysteine, 2003, Vol. 17(1) pp. 5
L-carnitine, 1999, Vol. 13(2) pp. 4
L-carnosine, 2003, Vol. 17(1) pp. 1
large neutral amino acids (LNAAs), 1996, Vol. 10(1) pp. 6
phenylalanine, 1995, Vol. 09(2) pp. 4; 2003, Vol. 17(3) pp. 6.
Tarvil, 2003, Vol. 17(3) pp. 6
tryptophan, 1987, Vol. 01(4) pp. 6; 1990, Vol. 04(4) pp. 4; 1991, Vol. 05(3) pp. 1; 1993, Vol. 07(3) pp. 1; 1996, Vol. 10(1) pp. 6; 1996, Vol. 10(4) pp. 6.
tyrosine, 1990, Vol. 04(4) pp. 4; 2002, Vol. 16(1) pp. 7.

amino-aciduria, 1987, Vol. 01(4) pp. 4; 1988, Vol. 02(4) pp. 7.
Amir, R. E., 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(1) pp. 5.
Amminger, G.P., 2006, Vol. 20(4) pp. 6
ammonia blood levels, 1998, Vol. 12(3) pp. 3
Amos, Patricia A., 1991, Vol. 05(4) pp. 7
amoxicillin, 1992, Vol. 06(4) pp. 4
amphetamine drugs, 2006, Vol. 20(1) pp. 5
AMTA. See Access to Medical Treatment Act
amygdala deficiencies, 1987, Vol. 01(1) pp. 1

and face processing, 2005, Vol. 19(1) pp. 5; 2006, Vol. 20(4) pp. 2.
in high-functioning autistics, 2000, Vol. 14(4) pp. 2; 2001, Vol. 15(4) pp. 1.
and joint attention, 2001, Vol. 15(4) pp. 1
from mercury poisoning and autism compared, 2000, Vol. 14(2) pp. 7
neuronal, 2006, Vol. 20(4) pp. 5
in savants, 1989, Vol. 03(1) pp. 7
secretin for, 2004, Vol. 18(2) pp. 2
and social deficits, 2006, Vol. 20(4) pp. 7
and temporal lobe defects, 1992, Vol. 06(3) pp. 4
and "theory of mind," 2001, Vol. 15(4) pp. 1; 2004, Vol. 18(2) pp. 2.

amyotropic lateral sclerosis (ALS), 1995, Vol. 09(2) pp. 4
anaerobic cocci, 2000, Vol. 14(3) pp. 2
Anafranil. See clomipramine (Anafranil)
analogical reasoning test, 1997, Vol. 11(1) pp. 7
anaphylaxis, 1995, Vol. 09(1) pp. 1
Anders, Tom, 2000, Vol. 14(2) pp. 1
Andrasik, Frank, 1988, Vol. 02(3) pp. 5
androgens, 2006, Vol. 20(4) pp. 2
android, 2006, Vol. 20(1) pp. 7
anesthesia

atropine, 2000, Vol. 14(4) pp. 7
in birth delivery, 1991, Vol. 05(3) pp. 4
in dental work, 1999, Vol. 13(3) pp. 5; 2000, Vol. 14(4) pp. 7.
ketamine, 1999, Vol. 13(3) pp. 5; 2000, Vol. 14(4) pp. 7.
meripidine (Demerol), 1999, Vol. 13(3) pp. 5; 2000, Vol. 14(4) pp. 7.
midazolam (Versed), 1999, Vol. 13(3) pp. 5; 2000, Vol. 14(4) pp. 7.
propofol, 1999, Vol. 13(3) pp. 5
website on, 2000, Vol. 14(4) pp. 7

anesthetic cream, 2003, Vol. 17(4) pp. 5
aneuploidy of the oocytes, 2003, Vol. 17(2) pp. 6
Angell, Marcia, 2004, Vol. 18(3) pp. 5
Angelman's syndrome, 1997, Vol. 11(4) pp. 4; 2001, Vol. 15(4) pp. 3; 2003, Vol. 17(1) pp. 6; 2004, Vol. 18(4) pp. 6.
"Anger Buster," 1996, Vol. 10(1) pp. 7
"anger management assessment," 1997, Vol. 11(4) pp. 5
animal therapy, 1989, Vol. 03(4) pp. 2
anorexia nervosa and autism, 1988, Vol. 02(1) pp. 1
anoxia, 1988, Vol. 02(2) pp. 7
anterior cingulate, 2006, Vol. 20(2) pp. 7
anthrax, 2002, Vol. 16(4) pp. 3
anti-androgens, 2005, Vol. 19(1) pp. 2
anti-convulsants. See also individual drugs

and aplastic anemia, 1994, Vol. 08(3) pp. 2
felbamate, 1993, Vol. 07(4) pp. 5; 1994, Vol. 08(2) pp. 7; 1994, Vol. 08(3) pp. 2.
vagus nerve stimulator for reducing dependence on, 2001, Vol. 15(2) pp. 7
valproic acid, 1994, Vol. 08(2) pp. 7
and vitamin D deficiency, 2004, Vol. 18(3) pp. 4

anti-depressants, 2003, Vol. 17(2) pp. 4; 2004, Vol. 18(3) pp. 2; 2004, Vol. 18(4) pp. 4; 2006, Vol. 20(2) pp. 2. See also selective serotonin reuptake inhibitors, individual antidepressants
anti-gliadin IgG positive, 2000, Vol. 14(3) pp. 6
anti-human antibodies. See autoimmune disorders
anti-MBP, 1999, Vol. 13(1) pp. 4; 2002, Vol. 16(1) pp. 6.
antibiotics

and allergies, 2004, Vol. 18(2) pp. 7; 2006, Vol. 20(1) pp. 5.
and autism increase, 1995, Vol. 09(3) pp. 3; 2006, Vol. 20(4) pp. 6.
and candida, 1988, Vol. 02(2) pp. 3; 1995, Vol. 09(3) pp. 3.
for ear infections, 1992, Vol. 06(4) pp. 4; 1994, Vol. 08(4) pp. 1; 1995, Vol. 09(3) pp. 3; 1997, Vol. 11(1) pp. 7; 1998, Vol. 12(4) pp. 1; 2000, Vol. 14(3) pp. 2; 2001, Vol. 15(4) pp. 7; 2006, Vol. 20(4) pp. 6.
and mercury excretion, 2001, Vol. 15(4) pp. 7
and probiotics, 2001, Vol. 15(3) pp. 4
and tetanus of intestines, 1998, Vol. 12(4) pp. 1
vancomycin, 2000, Vol. 14(3) pp. 2

anticonvulsants

and cannabinoids compared, 2003, Vol. 17(4) pp. 4
and cardiovascular damage, 2003, Vol. 17(1) pp. 5; 2005, Vol. 19(4) pp. 7.
drug therapy timing, 2005, Vol. 19(2) pp. 4
and self-injuring behaviors, 1993, Vol. 07(1) pp. 4

antihistamines and grapefruit juice, 1997, Vol. 11(3) pp. 6
antimony, 2006, Vol. 20(1) pp. 3
antioxidant capacity, 2004, Vol. 18(4) pp. 1
antioxidants, 2005, Vol. 19(2) pp. 6; 2005, Vol. 19(4) pp. 1; 2006, Vol. 20(3) pp. 6.
antiphospholipid antibodies, 2001, Vol. 15(1) pp. 7
antipsychotics. See also individual drugs

and blood clots, 2000, Vol. 14(4) pp. 4; 2006, Vol. 20(3) pp. 6.
and cardiovascular disease, 2005, Vol. 19(1) pp. 6
and diabetes, 1999, Vol. 13(3) pp. 2; 2001, Vol. 15(4) pp. 5; 2002, Vol. 16(2) pp. 6; 2002, Vol. 16(4) pp. 6; 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(2) pp. 2; 2005, Vol. 19(1) pp. 6; 2006, Vol. 20(3) pp. 6.
and hyperlipidemia, 2005, Vol. 19(1) pp. 6
and insulin resistance, 2005, Vol. 19(1) pp. 6
and metabolic syndrome, 2006, Vol. 20(3) pp. 6
and obesity, 2005, Vol. 19(1) pp. 6
and protein in urine, 2005, Vol. 19(1) pp. 6
risperidone and ziprazidone compared, 2004, Vol. 18(1) pp. 6

anxiety

in depressive disorders, 1999, Vol. 13(2) pp. 6
diet for, 2002, Vol. 16(3) pp. 1
drugs and, 1987, Vol. 01(3) pp. 4; 1994, Vol. 08(3) pp. 4; 1997, Vol. 11(1) pp. 2; 1997, Vol. 11(2) pp. 7; 1998, Vol. 12(3) pp. 1; 1999, Vol. 13(2) pp. 2; 2001, Vol. 15(1) pp. 4.
from influenza in-utero, 2003, Vol. 17(2) pp. 2
marijuana for, 2002, Vol. 16(2) pp. 7
neurofeedback therapy for, 2003, Vol. 17(1) pp. 2
and PDD, 1996, Vol. 10(4) pp. 2; 1998, Vol. 12(4) pp. 4.
separation anxiety, 1998, Vol. 12(2) pp. 2
and serotonin transporter gene, 1997, Vol. 11(2) pp. 2
and sleep disorders, 1998, Vol. 12(4) pp. 5
squeeze machine for, 1998, Vol. 12(3) pp. 1
supplements for, 1990, Vol. 04(4) pp. 7; 1999, Vol. 13(1) pp. 2; 2000, Vol. 14(2) pp. 4.
and theory of mind, 1998, Vol. 12(4) pp. 6
Tourette's and, 1991, Vol. 05(3) pp. 1

AOL disAbilities Forum, 1994, Vol. 08(3) pp. 6
aphasias, 1991, Vol. 05(1) pp. 2
aplastic anemia, 1994, Vol. 08(3) pp. 2
apnea, 1999, Vol. 13(3) pp. 1
apoptosis, 2005, Vol. 19(2) pp. 4; 2006, Vol. 20(1) pp. 5.
Aposhian, Vasken, 2006, Vol. 20(3) pp. 6
appetite increase

5-HTP for, 1999, Vol. 13(1) pp. 7
from quetiapine fumarate (Seroquel), 1999, Vol. 13(4) pp. 4
from risperidone (Risperdal), 1997, Vol. 11(3) pp. 2

Applied Behavior Analysis (ABA). See also Lovaas, O. Ivar

for attention, 2002, Vol. 16(2) pp. 2
for babies, 2002, Vol. 16(2) pp. 2
and cognitive improvement, 2002, Vol. 16(1) pp. 2
and complementary treatments, 1999, Vol. 13(3) pp. 3; 2000, Vol. 14(1) pp. 7.
"discrete trial" instruction, 2002, Vol. 16(2) pp. 2
in early intervention, 1999, Vol. 13(4) pp. 6; 2002, Vol. 16(3) pp. 5; 2003, Vol. 17(4) pp. 3; 2005, Vol. 19(3) pp. 1; 2006, Vol. 20(3) pp. 2.

apprenticeships, 1990, Vol. 04(3) pp. 6
apropterin HCL. See R-THBP
ARA (arachidonic acid), 2000, Vol. 14(4) pp. 6
ARC of California, 1997, Vol. 11(1) pp. 3
Arendt, R. E., 1995, Vol. 09(2) pp. 5
Arens, Helen, 1992, Vol. 06(4) pp. 6
arginine pyroglutamate, 1995, Vol. 09(1) pp. 6
arginine-vasopressin, 1996, Vol. 10(1) pp. 4
ARI (Autism Research International). See also Autism Research International, Institute for Child Behavioral Research
ARI (Autism Research International) Mercury Detoxification Consensus Protocol, 2001, Vol. 15(3) pp. 4
Aricept (donepezil), 2004, Vol. 18(2) pp. 5
arichodonic acid (ARA), 2000, Vol. 14(4) pp. 6
aripiprazole (Abilify), 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(2) pp. 2.
Armstrong, Jack and Carlene, 1990, Vol. 04(3) pp. 3
Arnold, Eugene, 1995, Vol. 09(3) pp. 7
Arnold-Chiari Malformations, 2006, Vol. 20(3) pp. 7
Aron, Marilyn, 1990, Vol. 04(3) pp. 5
Aronson, Marita, 1998, Vol. 12(1) pp. 5
ARRI. See Autism Research Review International (ARRI)
Arrieta, Isabel, 1996, Vol. 10(4) pp. 4
Arrieta, M. I., 1990, Vol. 04(2) pp. 4
arsenic, 2002, Vol. 16(3) pp. 4; 2006, Vol. 20(1) pp. 3; 2006, Vol. 20(2) pp. 1; 2006, Vol. 20(3) pp. 7; 2006, Vol. 20(4) pp. 1.
arthritis and rubella vaccine, 1995, Vol. 09(1) pp. 7
artificial coloring, 2000, Vol. 14(1) pp. 2; 2005, Vol. 19(4) pp. 1.
Artinian, Miriam, 1989, Vol. 03(1) pp. 5
Ashby, Lesley, 1991, Vol. 05(1) pp. 5
Ashkenazi Jews, 1995, Vol. 09(2) pp. 4
Ashwood, Paul, 2005, Vol. 19(1) pp. 4
Asian Americans, 2000, Vol. 14(1) pp. 4
aspartame, 1992, Vol. 06(2) pp. 4; 1997, Vol. 11(4) pp. 2; 2005, Vol. 19(4) pp. 1.
aspartate, 2005, Vol. 19(4) pp. 5
Aspects of Autism: Biological Research (ed. Wing), 1989, Vol. 03(4) pp. 7
Asperger, Hans, 1988, Vol. 02(4) pp. 7
Asperger's Syndrome

and acrocyanosis, 1990, Vol. 04(3) pp. 4
and amino-aciduria, 1987, Vol. 01(4) pp. 4
ARI's website, 2006, Vol. 20(4) pp. 3
and autism compared, 1988, Vol. 02(4) pp. 1; 1989, Vol. 03(1) pp. 4; 1995, Vol. 09(2) pp. 6.
and Autism Treatment Evaluation Checklist, 2006, Vol. 20(4) pp. 4
brain abnormalities in, 1988, Vol. 02(4) pp. 7; 1995, Vol. 09(4) pp. 5.
clumsiness, 1995, Vol. 09(2) pp. 6
co-morbid conditions, 1994, Vol. 08(2) pp. 4
cognitive style, 2000, Vol. 14(4) pp. 5
and coproporphyrin, 2006, Vol. 20(2) pp. 1
criminals with, 1988, Vol. 02(4) pp. 7
diagnosis, 1992, Vol. 06(1) pp. 4
as "difference" rather than "disability," 2000, Vol. 14(4) pp. 5
face blindness in, 1995, Vol. 09(3) pp. 2
and fetal alcohol, 1998, Vol. 12(1) pp. 5
genetic factors, 1988, Vol. 02(1) pp. 2; 1988, Vol. 02(4) pp. 7; 1989, Vol. 03(1) pp. 4; 2000, Vol. 14(4) pp. 5.
and Marfan's Syndrome, 1991, Vol. 05(1) pp. 4
and masculine brains, 2006, Vol. 20(1) pp. 4
and motor delays, 2004, Vol. 18(3) pp. 5
and non-organic autism, 1988, Vol. 02(2) pp. 5
prevalence of, 1990, Vol. 04(3) pp. 4
psychosis in, 1988, Vol. 02(4) pp. 7; 1989, Vol. 03(1) pp. 4.
sibling study, 2004, Vol. 18(1) pp. 5
supplements for, 1995, Vol. 09(1) pp. 7
and violence, 1995, Vol. 09(2) pp. 6

asphyxia-autism link, 2004, Vol. 18(1) pp. 6
asphyxiation, 1988, Vol. 02(2) pp. 7
assistive technology. See also communication devices

Web Trek Connect, 2001, Vol. 15(3) pp. 5
association, functional

B6/magnesium for, 1990, Vol. 04(2) pp. 4
Association for Persons with Severe Handicaps (TASH), 1988, Vol. 02(3) pp. 6

Association for Science in Autistic Treatment, 1999, Vol. 13(3) pp. 3
Association of American Physicians and Surgeons, 1999, Vol. 13(3) pp. 1
associative auditory cortex, 2001, Vol. 15(1) pp. 6
Assumpcao, F. B., Jr., 1998, Vol. 12(3) pp. 4
asthma, 1999, Vol. 13(3) pp. 4; 2004, Vol. 18(2) pp. 7; 2006, Vol. 20(1) pp. 5.
astroglia, 2004, Vol. 18(4) pp. 1–2
asylums. See institutions
ATEC (Autism Treatment EvaluationChecklist), 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(2) pp. 6; 2006, Vol. 20(4) pp. 4.
Athanas-Brayton, Evelyn, 1998, Vol. 12(1) pp. 7
atherosclerotic vascular disease, 2003, Vol. 17(1) pp. 5
Atkins diet, 2004, Vol. 18(1) pp. 2
ATP (adenosine triphosphate), 1999, Vol. 13(3) pp. 4
atropine, 2000, Vol. 14(4) pp. 7
attachment hormone, 1993, Vol. 07(4) pp. 4
attention. See also concentration

Applied Behavior Analysis (ABA) for, 2002, Vol. 16(2) pp. 2
B6 for, 1992, Vol. 06(1) pp. 7; 1993, Vol. 07(1) pp. 7; 1994, Vol. 08(3) pp. 6; 1994, Vol. 08(4) pp. 7; 1996, Vol. 10(3) pp. 7; 2001, Vol. 15(2) pp. 6.
brain abnormalities and, 1992, Vol. 06(4) pp. 1; 1994, Vol. 08(2) pp. 1; 1996, Vol. 10(1) pp. 4; 1997, Vol. 11(2) pp. 4; 2001, Vol. 15(3) pp. 4; 2001, Vol. 15(4) pp. 1.
DMG for, 1987, Vol. 01(4) pp. 5; 1993, Vol. 07(2) pp. 6; 1994, Vol. 08(2) pp. 6; 1994, Vol. 08(3) pp. 6.
drugs for, 1990, Vol. 04(2) pp. 4; 1992, Vol. 06(1) pp. 1; 1993, Vol. 07(4) pp. 4; 1997, Vol. 11(1) pp. 2; 2000, Vol. 14(2) pp. 4; 2003, Vol. 17(4) pp. 7.
focusing training for self-stimulating behaviors, 1998, Vol. 12(1) pp. 2
gluten-free diet for, 1999, Vol. 13(2) pp. 6
joint attention, 2001, Vol. 15(4) pp. 1
kinds of, 1990, Vol. 04(2) pp. 4
magnesium for, 1994, Vol. 08(3) pp. 6; 1994, Vol. 08(4) pp. 7; 2001, Vol. 15(2) pp. 6.
massage therapy for, 2002, Vol. 16(1) pp. 5
melatonin for, 1994, Vol. 08(3) pp. 1
and mercury, 2003, Vol. 17(2) pp. 7
omega-3 fatty acids for, 2002, Vol. 16(2) pp. 4
and operant conditioning, 1994, Vol. 08(3) pp. 3
and PANDAS (pediatric autoimmune neuropsychiatric disorders), 1998, Vol. 12(2) pp. 2
PECS (Picture Exchange Communication System) for, 2002, Vol. 16(4) pp. 2
prism lenses for, 1998, Vol. 12(3) pp. 6
in savants, 1989, Vol. 03(1) pp. 3
secretin for, 1998, Vol. 12(3) pp. 3
seeking of, 2001, Vol. 15(2) pp. 6
sensory integration therapy for, 1999, Vol. 13(2) pp. 5
supplements for, 2003, Vol. 17(4) pp. 7

attention deficit disorder (ADD)

and dopamine allele, 1992, Vol. 06(2) pp. 4
from fetal alcohol, 1998, Vol. 12(1) pp. 5
from frontal lobe seizures, 1992, Vol. 06(1) pp. 4; 1993, Vol. 07(1) pp. 4.
and herpes simplex, 1997, Vol. 11(2) pp. 2
Latitudes (newsletter), 1994, Vol. 08(2) pp. 6
and mercury, 2000, Vol. 14(3) pp. 1; 2003, Vol. 17(1) pp. 2.
misdiagnosis pitfalls, 1992, Vol. 06(3) pp. 5
and Mycoplasma pneumoniae, 2000, Vol. 14(2) pp. 4
neurofeedback for, 2003, Vol. 17(1) pp. 2
newletter on alternative therapies for, 1994, Vol. 08(2) pp. 6
speech patterns compared to Fragile X, 1988, Vol. 02(2) pp. 5
and Tourette's, 1991, Vol. 05(3) pp. 1
zinc for, 2004, Vol. 18(2) pp. 5

attention deficit hyperactivity disorder (ADHD)

black box warning on drugs for, 2006, Vol. 20(1) pp. 5; 2006, Vol. 20(2) pp. 2.
Cylert banned, 2005, Vol. 19(3) pp. 4
essential fatty acids and, 2005, Vol. 19(1) pp. 1; 2005, Vol. 19(4) pp. 2; 2006, Vol. 20(2) pp. 3.
fenfluramine for, 1993, Vol. 07(4) pp. 4
and food additives, 2004, Vol. 18(3) pp. 2
and gut disorders, 2002, Vol. 16(3) pp. 2
mecamylamine for, 1998, Vol. 12(4) pp. 2
neurofeedback for, 2006, Vol. 20(2) pp. 4
and neuropathy target enterase (NTE) deficiency, 2003, Vol. 17(1) pp. 6
and omega-3-fatty acids level, 1999, Vol. 13(1) pp. 7
pycnogenol for, 2006, Vol. 20(2) pp. 6; 2006, Vol. 20(4) pp. 7.
sensory therapy for, 2005, Vol. 19(2) pp. 5
supplements for, 1995, Vol. 09(1) pp. 3; 2001, Vol. 15(2) pp. 6; 2003, Vol. 17(4) pp. 7; 2006, Vol. 20(2) pp. 6.
and thimerosol, 2004, Vol. 18(1) pp. 1
and toxins, 2000, Vol. 14(3) pp. 1

attentuated vaccine strains, 2000, Vol. 14(4) pp. 2
atypical nevi, 1998, Vol. 12(1) pp. 4
Audhya, Tapan, 2005, Vol. 19(2) pp. 6
audiograms, 1990, Vol. 04(4) pp. 3
audiometry, 1991, Vol. 05(1) pp. 2
auditory brainstem response (ABR) test, 1988, Vol. 02(4) pp. 4; 1993, Vol. 07(2) pp. 4.
auditory cortex, associative, 2001, Vol. 15(1) pp. 6
auditory integration therapy (AIT). See also hearing abnormalities

audiogram difficulties, 1998, Vol. 12(3) pp. 7
brain changes from, 1999, Vol. 13(3) pp. 5
devices, 1993, Vol. 07(3) pp. 2; 1995, Vol. 09(4) pp. 2.
and drugs, 1991, Vol. 05(1) pp. 3
evaluations of, 1992, Vol. 06(2) pp. 1; 1999, Vol. 13(2) pp. 2.
packages, 1992, Vol. 06(4) pp. 3; 1994, Vol. 08(2) pp. 6.
for sound sensitivity, 1990, Vol. 04(4) pp. 3
studies, 1988, Vol. 02(2) pp. 2; 1991, Vol. 05(3) pp. 1.
and supplements, 1991, Vol. 05(1) pp. 3
trainers, 1988, Vol. 02(2) pp. 5

auditory processing problems

and ear wax, 1999, Vol. 13(2) pp. 7
in Fragile X, 2001, Vol. 15(3) pp. 4
and myelination defect, 1993, Vol. 07(1) pp. 5
with vowel changes, 2003, Vol. 17(2) pp. 4

Augmentin, 2005, Vol. 19(1) pp. 6
August, Gerald, 1987, Vol. 01(3) pp. 2
Autism: Nature, Diagnosis and Treatment (Bourgondien and Mesibov), 1990, Vol. 04(3) pp. 1
Autism: New Directions in Research and Education (ed. Webster, Konstantareas, Oxman and Mack), 1991, Vol. 05(1) pp. 7
Autism: The International Journal of Research and Practice (journal), 1997, Vol. 11(2) pp. 6
Autism: The Ultimate Stranger (Delacato), 1990, Vol. 04(4) pp. 3
Autism A.L.A.R.M., 2004, Vol. 18(2) pp. 3
Autism and Allergies: To the Parents of Kids Like Tony (Callahan), 1989, Vol. 03(2) pp. 3
Autism Autoimmunity Project, 2003, Vol. 17(1) pp. 7
Autism Awareness Week, 1995, Vol. 09(2) pp. 3
autism clusters

Brick (NJ), 1997, Vol. 11(4) pp. 2; 1999, Vol. 13(1) pp. 1; 2000, Vol. 14(2) pp. 1.
Cambridgeshire (UK), 2000, Vol. 14(2) pp. 1
Houston (TX), 1997, Vol. 11(4) pp. 2
Leominster (MA), 1990, Vol. 04(4) pp. 6; 1992, Vol. 06(2) pp. 1; 1993, Vol. 07(3) pp. 5; 1995, Vol. 09(3) pp. 3.
Oakland (CA), 1997, Vol. 11(4) pp. 2; 1999, Vol. 13(1) pp. 1.
West Virginia, 2004, Vol. 18(1) pp. 5
Westport (CT), 1997, Vol. 11(4) pp. 2

Autism Discussion Group, 1994, Vol. 08(4) pp. 7
autism epidemic, 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(1) pp. 3; 2000, Vol. 14(2) pp. 7; 2004, Vol. 18(3) pp. 3; 2004, Vol. 18(4) pp. 5; 2005, Vol. 19(3) pp. 1; 2005, Vol. 19(4) pp. 5. See also autism clusters
Autism et Troubles du Developpement Global de L'Enfant (Le Lord, Muh, Petit, and Sauvage), 1990, Vol. 04(1) pp. 7
autism Internet discussion group, 1995, Vol. 09(3) pp. 7
Autism Is Treatable campaign, 2003, Vol. 17(4) pp. 1; 2004, Vol. 18(2) pp. 1; 2005, Vol. 19(2) pp. 8.
Autism Network for Dietary Intervention (ANDI), 2002, Vol. 16(3) pp. 7
Autism Project, 1995, Vol. 09(1) pp. 6
Autism Research International (ARI), 2006, Vol. 20(4) pp. 1 See also Institute for Child Behavioral Research
Autism Research International Mercury Detoxification Consensus Protocol, 2001, Vol. 15(1) pp. 1; 2001, Vol. 15(3) pp. 4.
Autism Research Review International (ARRI), 1987, Vol. 01(1) pp. 1; 1987, Vol. 01(2) pp. 3; 1997, Vol. 11(2) pp. 4; 2002, Vol. 16(2) pp. 3; 2003, Vol. 17(4) pp. 3.
website, 2000, Vol. 14(4) pp. 3
Autism Society of America

and Autism Research Institute, collaboration with, 2006, Vol. 20(4) pp. 1
on aversives, 1988, Vol. 02(3) pp. 1; 1989, Vol. 03(4) pp. 1.
DAN! Protocol panel, 2001, Vol. 15(2) pp. 1
founding of, 1992, Vol. 06(3) pp. 3; 1994, Vol. 08(3) pp. 3; 1994, Vol. 08(4) pp. 7; 1995, Vol. 09(2) pp. 3; 2003, Vol. 17(4) pp. 3; 2006, Vol. 20(3) pp. 1.

Autism Society of Michigan, 1994, Vol. 08(4) pp. 7
Autism Summit, 2003, Vol. 17(4) pp. 1; 2005, Vol. 19(2) pp. 8.
Autism Treatment Evaluation Checklist (ATEC), 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(2) pp. 6; 2006, Vol. 20(4) pp. 4.
Autism Treatment Network, 2005, Vol. 19(1) pp. 3
Autistic Adults at Bittersweet Farms (ed. Giddan and Giddan), 1990, Vol. 04(3) pp. 3; 1991, Vol. 05(2) pp. 7; 1995, Vol. 09(1) pp. 7.
Autistic Behavior Checklist, 1992, Vol. 06(3) pp. 5
Autistic Children: New Hope for a Cure (Tinbergen), 1987, Vol. 01(3) pp. 3
autoantibodies, brain

to brain regions, 1988, Vol. 02(2) pp. 4; 2004, Vol. 18(1) pp. 6; 2004, Vol. 18(3) pp. 7; 2004, Vol. 18(4) pp. 1.
in Landau-Kleffner syndrome, 1999, Vol. 13(2) pp. 4; 2001, Vol. 15(1) pp. 7.
and measles-mumps-rubella vaccine, 2000, Vol. 14(4) pp. 1; 2002, Vol. 16(1) pp. 6; 2004, Vol. 18(2) pp. 1.
viral link, 1999, Vol. 13(1) pp. 4

autoimmune disorders, 1991, Vol. 05(1) pp. 2

antibrain antibodies (See autoantibodies, brain)
antiphospholipid antibodies and epilepsy, 2001, Vol. 15(1) pp. 7
in autism families, 1997, Vol. 11(4) pp. 5; 2003, Vol. 17(4) pp. 2.
autoantibodies, brain (See autoantibodies, brain)
autoimmune lymphoproliferative syndrome (ALPS), 2000, Vol. 14(3) pp. 5
bipolar and autism, 1988, Vol. 02(1) pp. 1; 1991, Vol. 05(3) pp. 1.
and casein, 2002, Vol. 16(3) pp. 6
celiac disease, 2001, Vol. 15(1) pp. 2
"dose effect" in autistics' family members, 1997, Vol. 11(4) pp. 5
and family history in autistics, 2006, Vol. 20(2) pp. 2
gold for, 2006, Vol. 20(1) pp. 4
Landau-Kleffner syndrome as, 1999, Vol. 13(2) pp. 4
and liver detoxification defects in autistics, 1998, Vol. 12(3) pp. 2
lymphocyte receptor DR+, 1994, Vol. 08(2) pp. 4
lymphocytic colitis, 2001, Vol. 15(1) pp. 2
and measles mumps rubella (MMR) vaccine, 2000, Vol. 14(1) pp. 3
NK (non-killer) cells study, 1987, Vol. 01(2) pp. 2
PANDAS (pediatric autoimmune neuropsychiatric disorders), 1998, Vol. 12(2) pp. 2
and seizures, 2001, Vol. 15(1) pp. 7
and thimerosol, 2004, Vol. 18(1) pp. 6; 2004, Vol. 18(4) pp. 4; 2005, Vol. 19(1) pp. 4; 2005, Vol. 19(4) pp. 5; 2006, Vol. 20(1) pp. 1.
Tourette's and autism, 1988, Vol. 02(1) pp. 1; 1991, Vol. 05(3) pp. 1.
tuberous sclerosis, 1993, Vol. 07(3) pp. 4
from vaccines, 1999, Vol. 13(3) pp. 7; 2000, Vol. 14(4) pp. 1; 2002, Vol. 16(3) pp. 1; 2004, Vol. 18(2) pp. 5.
and zonulin, 2000, Vol. 14(2) pp. 2

autoimmune lymphoproliferative syndrome (ALPS), 2000, Vol. 14(3) pp. 5
autosomal abnormalities

Asperger's as, 1988, Vol. 02(4) pp. 7
and fingerprints, 1990, Vol. 04(2) pp. 4
and sex-linked abnormalities compared, 1987, Vol. 01(2) pp. 4
single gene ruled out in, 1989, Vol. 03(2) pp. 2

Aversive and Nonaversive Interventions (ed. Harris and Handleman), 1991, Vol. 05(2) pp. 7
aversives

Alternatives for People with Autism, Inc., 1988, Vol. 02(3) pp. 8
American Medical Association on, 1989, Vol. 03(2) pp. 2
DRO (differential reinforcement of other behaviors) and, 1989, Vol. 03(1) pp. 5
and drugs compared, 1988, Vol. 02(3) pp. 8; 1989, Vol. 03(4) pp. 1.
in early intervention programs, 2000, Vol. 14(4) pp. 2; 2005, Vol. 19(3) pp. 1.
for eating refusal, 1989, Vol. 03(1) pp. 5
exercise, 1988, Vol. 02(4) pp. 3
and Gentle Teaching compared, 1989, Vol. 03(3) pp. 1–2
HSP 3012, 1996, Vol. 10(4) pp. 1–2
hugging, 1987, Vol. 01(1) pp. 5
Judge Rotenberg versus Department of Mental Retardation, 1995, Vol. 09(4) pp. 2; 1997, Vol. 11(3) pp. 5.
Lovaas' use of, 1987, Vol. 01(1) pp. 3
NIH Consensus Development Conference on the Treatment of Destructive Behaviors, 1989, Vol. 03(4) pp. 1; 1990, Vol. 04(4) pp. 3; 1992, Vol. 06(2) pp. 1.
and nonaversives compared, 2001, Vol. 15(4) pp. 3
SIBIS (Self-Injury-Behavior-Intervention-System), 1989, Vol. 03(4) pp. 3; 1990, Vol. 04(2) pp. 6; 1994, Vol. 08(2) pp. 4; 1995, Vol. 09(4) pp. 2; 1996, Vol. 10(2) pp. 3; 1996, Vol. 10(4) pp. 1.
as unethical, 1994, Vol. 08(3) pp. 6
water spraying for self-injury, 1989, Vol. 03(4) pp. 6; 1992, Vol. 06(2) pp. 5.

Awad, George, 1996, Vol. 10(4) pp. 2
awareness

auditory integration training for, 1999, Vol. 13(2) pp. 2
and autism epidemic perception, 2001, Vol. 15(3) pp. 3
diets for, 1999, Vol. 13(2) pp. 6; 2001, Vol. 15(1) pp. 6.
secretin for, 1998, Vol. 12(4) pp. 3; 1999, Vol. 13(3) pp. 2.

Ayres, A. Jean, 1991, Vol. 05(2) pp. 3
AZT, 1995, Vol. 09(2) pp. 5